Ocrevus (ocrelizumab) costs

Neurology

Buy Ocrevus (ocrelizumab) Online

• Disease Indications: Multiple Sclerosis
• Manufacturer: Roche Registration Limited
• Usage: Intravenous
• Medicine approved by:
• European Medical Agency (EMA)
• Food and Drug Administration (FDA)
• Health Canada
• Therapeutic Goods Administration (TGA)
• Medsafe (NZ)

Ocrevus (ocrelizumab) is a breakthrough treatment approved for patients with relapsing forms of multiple sclerosis (MS) as well as primary progressive MS, marking the first-ever therapy specifically authorized for this progressive form of the disease.

Select optionsThis product has multiple variants. The options may be chosen on the product page